Get it on Google Play

GRI Bio to present Phase 2a IPF data at Boston summit

September 28, 2026 8:40 AM EDT Send to a Friend
GRI Bio, Inc. (NASDAQ: GRI) announced that its Chief Executive Officer Marc Hertz and Chief Scientific Officer Vipin Kumar will ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login